Cite
Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice.
MLA
Zabana, Y., et al. “Infliximab Safety Profile and Long-Term Applicability in Inflammatory Bowel Disease: 9-Year Experience in Clinical Practice.” Alimentary Pharmacology & Therapeutics, vol. 31, no. 5, Mar. 2010, pp. 553–60. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2009.04206.x.
APA
Zabana, Y., Domènech, E., Mañosa, M., Garcia-Planella, E., Bernal, I., Cabré, E., & Gassull, M. A. (2010). Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice. Alimentary Pharmacology & Therapeutics, 31(5), 553–560. https://doi.org/10.1111/j.1365-2036.2009.04206.x
Chicago
Zabana, Y, E Domènech, M Mañosa, E Garcia-Planella, I Bernal, E Cabré, and M A Gassull. 2010. “Infliximab Safety Profile and Long-Term Applicability in Inflammatory Bowel Disease: 9-Year Experience in Clinical Practice.” Alimentary Pharmacology & Therapeutics 31 (5): 553–60. doi:10.1111/j.1365-2036.2009.04206.x.